-
Je něco špatně v tomto záznamu ?
Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid
J. Folbergrová, P. Ješina, R. Haugvicová, V. Lisý, J. Houštěk
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- agonisté excitačních aminokyselin farmakologie MeSH
- aldehydy metabolismus MeSH
- časové faktory MeSH
- down regulace účinky léků fyziologie MeSH
- energetický metabolismus účinky léků fyziologie MeSH
- epilepsie metabolismus patofyziologie MeSH
- homocystein analogy a deriváty toxicita MeSH
- konvulziva toxicita MeSH
- krysa rodu rattus MeSH
- metabolické sítě a dráhy fyziologie MeSH
- míra přežití MeSH
- mitochondriální nemoci chemicky indukované metabolismus patofyziologie MeSH
- mitochondrie účinky léků metabolismus MeSH
- modely nemocí na zvířatech MeSH
- mozková kůra metabolismus patologie patofyziologie MeSH
- novorozená zvířata MeSH
- oxidační stres účinky léků fyziologie MeSH
- potkani Wistar MeSH
- respirační komplex I účinky léků metabolismus MeSH
- scavengery volných radikálů farmakologie MeSH
- tyrosin analogy a deriváty metabolismus MeSH
- záchvaty chemicky indukované metabolismus patofyziologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Our previous work demonstrated the marked decrease of mitochondrial complex I activity in the cerebral cortex of immature rats during the acute phase of seizures induced by bilateral intracerebroventricular infusion of dl-homocysteic acid (600 nmol/side) and at short time following these seizures. The present study demonstrates that the marked decrease ( approximately 60%) of mitochondrial complex I activity persists during the long periods of survival, up to 5 weeks, following these seizures, i.e. periods corresponding to the development of spontaneous seizures (epileptogenesis) in this model of seizures. The decrease was selective for complex I and it was not associated with changes in the size of the assembled complex I or with changes in mitochondrial content of complex I. Inhibition of complex I was accompanied by a parallel, up to 5 weeks lasting significant increase (15-30%) of three independent mitochondrial markers of oxidative damage, 3-nitrotyrosine, 4-hydroxynonenal and protein carbonyls. This suggests that oxidative modification may be most likely responsible for the sustained deficiency of complex I activity although potential role of other factors cannot be excluded. Pronounced inhibition of complex I was not accompanied by impaired ATP production, apparently due to excess capacity of complex I documented by energy thresholds. The decrease of complex I activity was substantially reduced by treatment with selected free radical scavengers. It could also be attenuated by pretreatment with (S)-3,4-DCPG (an agonist for subtype 8 of group III metabotropic glutamate receptors) which had also a partial antiepileptogenic effect. It can be assumed that the persisting inhibition of complex I may lead to the enhanced production of reactive oxygen and/or nitrogen species, contributing not only to neuronal injury demonstrated in this model of seizures but also to epileptogenesis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025453
- 003
- CZ-PrNML
- 005
- 20130129170137.0
- 007
- ta
- 008
- 120816s2010 enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.neuint.2009.11.011 $2 doi
- 035 __
- $a (PubMed)19931336
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Folbergrová, Jaroslava, $d 1932- $7 jn20000400705 $u Institute of Physiology, Academy of Sciences of the Czech Republic, vvi, Vídenská 1083, 142 20 Prague 4, Czech Republic. folbergr@biomed.cas.cz
- 245 10
- $a Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid / $c J. Folbergrová, P. Ješina, R. Haugvicová, V. Lisý, J. Houštěk
- 520 9_
- $a Our previous work demonstrated the marked decrease of mitochondrial complex I activity in the cerebral cortex of immature rats during the acute phase of seizures induced by bilateral intracerebroventricular infusion of dl-homocysteic acid (600 nmol/side) and at short time following these seizures. The present study demonstrates that the marked decrease ( approximately 60%) of mitochondrial complex I activity persists during the long periods of survival, up to 5 weeks, following these seizures, i.e. periods corresponding to the development of spontaneous seizures (epileptogenesis) in this model of seizures. The decrease was selective for complex I and it was not associated with changes in the size of the assembled complex I or with changes in mitochondrial content of complex I. Inhibition of complex I was accompanied by a parallel, up to 5 weeks lasting significant increase (15-30%) of three independent mitochondrial markers of oxidative damage, 3-nitrotyrosine, 4-hydroxynonenal and protein carbonyls. This suggests that oxidative modification may be most likely responsible for the sustained deficiency of complex I activity although potential role of other factors cannot be excluded. Pronounced inhibition of complex I was not accompanied by impaired ATP production, apparently due to excess capacity of complex I documented by energy thresholds. The decrease of complex I activity was substantially reduced by treatment with selected free radical scavengers. It could also be attenuated by pretreatment with (S)-3,4-DCPG (an agonist for subtype 8 of group III metabotropic glutamate receptors) which had also a partial antiepileptogenic effect. It can be assumed that the persisting inhibition of complex I may lead to the enhanced production of reactive oxygen and/or nitrogen species, contributing not only to neuronal injury demonstrated in this model of seizures but also to epileptogenesis.
- 650 _2
- $a aldehydy $x metabolismus $7 D000447
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a novorozená zvířata $7 D000831
- 650 _2
- $a mozková kůra $x metabolismus $x patologie $x patofyziologie $7 D002540
- 650 _2
- $a konvulziva $x toxicita $7 D003292
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a down regulace $x účinky léků $x fyziologie $7 D015536
- 650 _2
- $a respirační komplex I $x účinky léků $x metabolismus $7 D042967
- 650 _2
- $a energetický metabolismus $x účinky léků $x fyziologie $7 D004734
- 650 _2
- $a epilepsie $x metabolismus $x patofyziologie $7 D004827
- 650 _2
- $a agonisté excitačních aminokyselin $x farmakologie $7 D018690
- 650 _2
- $a scavengery volných radikálů $x farmakologie $7 D016166
- 650 _2
- $a homocystein $x analogy a deriváty $x toxicita $7 D006710
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolické sítě a dráhy $x fyziologie $7 D053858
- 650 _2
- $a mitochondrie $x účinky léků $x metabolismus $7 D008928
- 650 _2
- $a mitochondriální nemoci $x chemicky indukované $x metabolismus $x patofyziologie $7 D028361
- 650 _2
- $a oxidační stres $x účinky léků $x fyziologie $7 D018384
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a záchvaty $x chemicky indukované $x metabolismus $x patofyziologie $7 D012640
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a tyrosin $x analogy a deriváty $x metabolismus $7 D014443
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ješina, Pavel $7 xx0102694
- 700 1_
- $a Haugvicová, Renata $7 xx0030584
- 700 1#
- $a Lisý, Václav. $7 xx0181582
- 700 1_
- $a Houštěk, Josef, $7 xx0030591 $d 1947-
- 773 0_
- $w MED00003485 $t Neurochemistry international $x 1872-9754 $g Roč. 56, č. 3 (2010), s. 394-403
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/19931336 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20130129170301 $b ABA008
- 999 __
- $a ok $b bmc $g 947495 $s 782799
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 56 $c 3 $d 394-403 $i 1872-9754 $m Neurochemistry international $n Neurochem Int $x MED00003485
- LZP __
- $a Pubmed-20120816/10/02